Skip to Content

Tempus AI and Merck Strengthen Partnership for Precision Medicine Biomarker Development

The collaboration underscores a strategic focus on advancing precision medicine through the...
March 3, 2026 by
Key Metrics

13.3

Heat Index
  • Impact Level
    Medium
  • Scope Level
    Global
  • Last Update
    2026-03-03
Key Impacts
Positive Impacts (9)
Merck & Co., Inc.
Tempus AI
Life-Science Tools & Reagents
Companion Diagnostics Companies
Genomic Sequencing Equipment Makers
Contract Research Organizations (CROs)
Total impacts: 9 | Positive: 9 | Negative: 0
Event Overview

The collaboration underscores a strategic focus on advancing precision medicine through the discovery and development of biomarkers, enhancing therapeutic efficacy and personalization in oncology and other areas.

Collect Records
Tempus AI and Merck Expand Collaboration for Precision Medicine Biomarkers
2026-03-03 21:54

Tempus AI has announced a long-term expanded collaboration with the pharmaceutical company Merck. The collaboration aims to accelerate the discovery and development of precision medicine biomarkers, supporting Merck's oncology pipeline and broader therapeutic areas.

Total records: 1
Iran Rejects US Proposal, Nuclear Talks Collapse, and Airstrikes Follow
The failure of nuclear negotiations highlights the deep-seated mistrust and intransigence between...